Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRAT1 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | URB2 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
mRNA | HOXD9 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | CAND2 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | NDUFAF2 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
mRNA | CPXM1 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | MBD1 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | C1orf146 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | E2F3 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |